Literature DB >> 7911532

In vitro analysis of virus-associated RNA I (VAI RNA): inhibition of the double-stranded RNA-activated protein kinase PKR by VAI RNA mutants correlates with the in vivo phenotype and the structural integrity of the central domain.

G D Ghadge1, P Malhotra, M R Furtado, R Dhar, B Thimmapaya.   

Abstract

Adenoviruses use the virus-encoded virus-associated RNA (VAI RNA) as a defense against cellular antiviral response by blocking the activation of the interferon-induced, double-stranded RNA-activated protein kinase PKR. The structure of VAI RNA consists of two long, imperfectly base-paired duplex regions connected by a complex short stem-loop at the center, referred to as the central domain. By using a series of adenovirus mutants with linker-scan mutations in the VAI RNA gene, we recently showed that the critical elements required for function in the VAI RNA molecule are in the central domain and that these same elements of the central domain are also involved in binding to PKR. In virus-infected cells, VAI RNA interacts with latent kinase, which is bound to ribosomes; this interaction takes place in a complex milieu. To more fully understand the relationship between structure and function and to determine whether the in vivo phenotype of these mutants can be reproduced in vitro, we have now analyzed these mutant VAI alleles for their ability to block the activation of a partially purified PKR from HeLa cells. We have also derived the structure of these mutants experimentally and correlated the structure with function. Without exception, when the structure of the short stem-loop of the central domain was perturbed, the mutants failed to inhibit PKR. Structural disruptions elsewhere in the central domain or in the long duplex regions of the molecule were not deleterious for in vitro function. Thus, these results support our previous findings and underscore the importance of the elements present in the central domain of the VAI RNA for its function. Our results also suggest that the interaction between PKR and VAI RNA involves a precise secondary (and tertiary) structure in the central domain. It has been suggested that VAI RNA does not activate PKR in virus-infected cells because of mismatches in the imperfectly base-paired long duplex regions. We constructed mutant VAI genes in which the imperfectly base-paired duplex regions were converted to perfectly base-paired regions and assayed in vitro for the activation of PKR. As with the wild-type VAI RNA, these mutants failed to activate PKR in vitro, while they were able to block the activation of PKR better than did the wild type. These results suggest that the failure of VAI RNA to activate PKR is not the result of mismatches in the long duplex regions.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911532      PMCID: PMC236337     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Direct chemical method for sequencing RNA.

Authors:  D A Peattie
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

2.  Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information.

Authors:  M Zuker; P Stiegler
Journal:  Nucleic Acids Res       Date:  1981-01-10       Impact factor: 16.971

3.  Mutational analysis of the central domain of adenovirus virus-associated RNA mandates a revision of the proposed secondary structure.

Authors:  T Pe'ery; K H Mellits; M B Mathews
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

4.  The characteristics of inhibition of protein synthesis by double-stranded ribonucleic acid in reticulocyte lysates.

Authors:  T Hunter; T Hunt; R J Jackson; H D Robertson
Journal:  J Biol Chem       Date:  1975-01-25       Impact factor: 5.157

5.  Silver staining of proteins in polyacrylamide gels.

Authors:  W Wray; T Boulikas; V P Wray; R Hancock
Journal:  Anal Biochem       Date:  1981-11-15       Impact factor: 3.365

6.  Procedures for studying transcription and translation of viral and host nucleic acids in interferon-treated cells.

Authors:  W K Joklik
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

7.  Binding of adenovirus VA RNA to mRNA: a possible role in splicing?

Authors:  M B Mathews
Journal:  Nature       Date:  1980-06-19       Impact factor: 49.962

8.  Structural requirements of double-stranded RNA for the activation of 2',5'-oligo(A) polymerase and protein kinase of interferon-treated HeLa cells.

Authors:  M A Minks; D K West; S Benvin; C Baglioni
Journal:  J Biol Chem       Date:  1979-10-25       Impact factor: 5.157

9.  Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection.

Authors:  B Thimmappaya; C Weinberger; R J Schneider; T Shenk
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

10.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

View more
  19 in total

1.  Viral dsRNA inhibitors prevent self-association and autophosphorylation of PKR.

Authors:  Sean A McKenna; Darrin A Lindhout; Takashi Shimoike; Colin Echeverría Aitken; Joseph D Puglisi
Journal:  J Mol Biol       Date:  2007-06-15       Impact factor: 5.469

Review 2.  Structure, function, and evolution of adenovirus-associated RNA: a phylogenetic approach.

Authors:  Y Ma; M B Mathews
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  Characterization and mapping of the double-stranded regions involved in activation of PKR within a cellular RNA from 3T3-F442A cells.

Authors:  R A Petryshyn; A G Ferrenz; J Li
Journal:  Nucleic Acids Res       Date:  1997-07-01       Impact factor: 16.971

4.  High level of transgene expression in cell cultures and in the mouse by replication-incompetent adenoviruses harboring modified VAI genes.

Authors:  M Eloit; M Adam; I Gallais; A Fournier
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Dissection of the adenoviral VA RNAI central domain structure reveals minimum requirements for RNA-mediated inhibition of PKR.

Authors:  Jo L Wilson; Virginia K Vachon; S Sunita; Samantha L Schwartz; Graeme L Conn
Journal:  J Biol Chem       Date:  2014-06-26       Impact factor: 5.157

6.  Effect of single-base substitutions in the central domain of virus-associated RNA I on its function.

Authors:  A Rahman; P Malhotra; R Dhar; T Kewalramani; B Thimmapaya
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

7.  Domain interactions in adenovirus VAI RNA mediate high-affinity PKR binding.

Authors:  Katherine Launer-Felty; James L Cole
Journal:  J Mol Biol       Date:  2014-01-04       Impact factor: 5.469

8.  The PKR-binding domain of adenovirus VA RNAI exists as a mixture of two functionally non-equivalent structures.

Authors:  Ahmed M Wahid; Veronica K Coventry; Graeme L Conn
Journal:  Nucleic Acids Res       Date:  2009-07-27       Impact factor: 16.971

9.  Structural features of adenovirus 2 virus-associated RNA required for binding to the protein kinase DAI.

Authors:  P A Clarke; T Pe'ery; Y Ma; M B Mathews
Journal:  Nucleic Acids Res       Date:  1994-10-25       Impact factor: 16.971

Review 10.  Noncoding RNAs produced by oncogenic human herpesviruses.

Authors:  Sankar Swaminathan
Journal:  J Cell Physiol       Date:  2008-08       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.